Cargando…

Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report

PURPOSE: To determine whether sentinel node detection (SNd) in muscle-invasive urothelial bladder cancer (MIBC) can be performed in patients undergoing neoadjuvant chemotherapy (NAC) and determine whether SNd is feasible in all pT stages, including pT0. BACKGROUND: Previous published series of SNd i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenblatt, Robert, Johansson, Markus, Alamdari, Farhood, Sidiki, Alexander, Holmström, Benny, Hansson, Johan, Vasko, Janos, Marits, Per, Gabrielsson, Susanne, Riklund, Katrine, Winqvist, Ola, Sherif, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486537/ https://www.ncbi.nlm.nih.gov/pubmed/27738804 http://dx.doi.org/10.1007/s00345-016-1952-x

Ejemplares similares

Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
por: Alvaeus, Julia, et al.
Publicado: (2019)

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
por: Hiltbrunner, Stefanie, et al.
Publicado: (2020)

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients
por: Zirakzadeh, A Ali, et al.
Publicado: (2015)

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours
por: Hartana, Ciputra Adijaya, et al.
Publicado: (2016)

Urothelial bladder cancer may suppress perforin expression in CD8(+) T cells by an ICAM-1/TGFβ2 mediated pathway
por: Hartana, Ciputra Adijaya, et al.
Publicado: (2018)

Increased CD4(+) T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
por: Ahlén Bergman, Emma, et al.
Publicado: (2018)

Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour
por: Eldh, Maria, et al.
Publicado: (2021)

Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
por: Karlsson, Mona, et al.
Publicado: (2010)

The many flavors of tumor-associated B cells
por: Marits, Per, et al.
Publicado: (2013)

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Rydell, Harriet, et al.
Publicado: (2022)

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
por: Sherif, Amir, et al.
Publicado: (2018)

The effect of chemotherapeutic drugs on human B lymphocytes
por: Zirakzadeh, Ali, et al.
Publicado: (2013)

Tissue‐resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer
por: Hartana, C. A., et al.
Publicado: (2018)

Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer—a Swedish retrospective multicentre study of a clinical database
por: Eriksson, Victoria, et al.
Publicado: (2022)

Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
por: Marits, P, et al.
Publicado: (2006)

Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer
por: Zhang, Lu, et al.
Publicado: (2021)

A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naïve Cystectomy Patients—A Study of a Clinical Multicentre Database
por: Eriksson, Victoria, et al.
Publicado: (2022)

The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy—A Multicentre Retrospective Cohort Study
por: Schulz Hägersten, Emma, et al.
Publicado: (2023)

Immune-Activated B Cells Are Dominant in Prostate Cancer
por: Saudi, Aws, et al.
Publicado: (2023)

Metinel Node—The First Lymph Node Draining a Metastasis—Contains Tumor-Reactive Lymphocytes
por: Dahl, Kjell, et al.
Publicado: (2008)

FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
por: Janson, Peter C. J., et al.
Publicado: (2008)

Outcomes and Prognostic Factors of Patients with Urothelial Carcinoma Undergoing Radical Cystectomy and pT0 in the Final Histology Without Neoadjuvant Chemotherapy
por: Rodler, Severin, et al.
Publicado: (2022)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

Neoadjuvant chemotherapy for upper tract urothelial carcinoma
por: Kim, Do Kyung, et al.
Publicado: (2020)

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
por: Patriarca, Carlo, et al.
Publicado: (2016)

Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy
por: Björeland, Ulrika, et al.
Publicado: (2021)

Challenging Visualization of Sentinel Lymph Nodes in Upper Urinary Tract Urothelial Carcinoma
por: Polom, Wojciech, et al.
Publicado: (2021)

Paediatricians face challenging times as COVID‐19 can cloud other diagnoses and lead to treatment delays
por: Marits, Ann Katrine, et al.
Publicado: (2020)

A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy
por: Klinga, Gustaf, et al.
Publicado: (2016)

Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis
por: Zhao, Guobin, et al.
Publicado: (2019)

White matter lesion load determines exercise-induced dopaminergic plasticity and working memory gains in aging
por: von Cederwald, Bryn Farnsworth, et al.
Publicado: (2023)

Activation of T helper cells in sentinel node predicts poor prognosis in oral squamous cell carcinoma
por: Kågedal, Åsa, et al.
Publicado: (2020)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
por: D’Andrea, David, et al.
Publicado: (2020)

Neoadjuvant Immunotherapy: The Next Gold Standard Before Radical Surgery for Urothelial Cancer
por: Raggi, Daniele, et al.
Publicado: (2021)

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
por: Li, Gang, et al.
Publicado: (2017)

Reliability of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Han, Ahram, et al.
Publicado: (2013)

Surgical management of the breast and axilla after neoadjuvant treatment: the role of sentinel node biopsy
por: Mamounas, EP
Publicado: (2009)

Internal Mammary Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer
por: Bi, Zhao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nb2uv95ockjlk73tqosr9laujf